Fintel reports that on April 10, 2023, Morgan Stanley maintained coverage of Royalty Pharma (NASDAQ:RPRX) with a Overweight recommendation. Analyst…
Sabine Royalty Trust said on April 6, 2023 that its board of directors declared a regular monthly dividend of $0.70…
In trading on Thursday, rental, leasing, & royalty shares were relative laggards, down on the day by about 1.9%. Helping…